Safe COVID-19 vaccines for Europeans

The European Commission has secured up to 4.4 billion doses of COVID-19 vaccines so far and negotiations are underway for additional doses. Vaccine deliveries to EU countries have increased steadily and vaccination is gathering pace. The Commission is also working with industry to step up vaccine manufacturing capacity.

At the same time it has started work to tackle new variants, aiming to rapidly develop and produce effective vaccines against these variants on a large scale. The HERA Incubator will help respond to this threat.

The EU is committed to ensuring that safe vaccines reach all corners of the world. The Commission and EU countries have pledged over €2.2 billion to COVAX, the global initiative aimed at ensuring equitable access to COVID-19 vaccines, and are supporting vaccination campaigns in partner countries.